Newsroom Stories

The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.

Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine and Saint Louis University School of Medicine.

Senior Amanda Sherman is back to ambush — ahem, interview — Washington University in St. Louis students (and a WashU canine) about the new academic year.

A new study from Washington University School of Medicine suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy, which is used to treat several cancers.

Three faculty from the Brown School and School of Medicine at Washington University in St. Louis have received a seven-year $6.1 million grant from the National Institutes of Health (NIH) for a project aimed at improving the health of mothers and children in the St. Louis region.

An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study in mice from researchers at Washington University School of Medicine in St. Louis and colleagues.

The Black Rep will launch its 46th season with “The African Company Presents Richard III.” The story, based on true events, chronicles the popular success of William Brown’s African Grove Theatre, established in New York in 1821, and the malicious campaign to shut it down.

Research from the McKelvey School of Engineering and School of Medicine aims to overcome a critical barrier in kidney disease research with a new way to culture specific kidney cells.

Washington University School of Medicine and BJC HealthCare are partnering with CuriMeta, a new company based in St. Louis, that will accelerate lifesaving research in the fight against chronic and acute diseases.

Physicists from Washington University in St. Louis are developing a new experiment as part of NASA’s Astrophysics Pioneers Program. Brian Rauch in Arts & Sciences is leading the effort, which will investigate the origins of heavy elements in the universe and has a $20 million cost cap.